The latest market report published by Acute Market Reports, Inc., the global market for photopheresis Products was valued at US$ 257 million in 2017 and is expected to reach US$ 418.56 million by 2026, expanding to CAGR by 5.5 per cent from 2018 to 2026.
Photopheresis uses apheresis and photodynamic therapy to treat blood with a photosensitizing agent followed by treatment with specified wavelengths of light. In photopheresis, buffy coat (WBC and platelets) is separated from the whole blood and then chemically treated with8-methoxypsoralene and exposed to ultraviolet-A light. As the prevalence of autoimmune diseases, ongoing research and development activities are being undertaken to develop the most appropriate treatments. Photopheresis is also seen as a promising treatment for transplant rejection, graft versus host disease, cutaneous T-cell lymphoma, and autoimmune diseases.
Browse Full Report Originally Published by Acute Market Reports at https://www.acutemarketreports.com/report/photopheresis-market
Based on product types, the global market for photopheresis products is segmented into closed systems and open systems. In 2017, the closed systems segment held the largest market share due to its advanced technology and the increasing preference of patients and physicians for the use of closed systems for photopheresis treatment. The popularity of closed systems is also attributed to their flexible use in all the therapeutic areas considered.
Among the considered therapeutic areas namely, autoimmune diseases, graft versus host disease, cutaneous T-cell lymphoma and solid organ transplant rejection, photopheresis finds highest application in autoimmune diseases. Graft versus host disease is observed as the largest segment in 2017 due to factors such as growing allogeneic transplantations, large number of chronic graft versus host disease patients, evolution of diagnostic technologies and consistently growing efforts in research and development activities.
Geographically, North America is the largest regional market for photopheresis. Presence of large pool of autoimmune disease patients, greater awareness in general population, well-structured reimbursement scenario and widespread presence of market incumbents contribute to the dominant position of North America. On the other hand, Asia Pacific is estimated to be the fastest progressing market for photopheresis. Rapidly developing healthcare infrastructure, significantly large patient pool and improving diagnostics front are the key growth drivers of Asia Pacific market.
The global photopheresis market is highly competitive and diversified, characterized by the presence of large number of players. The domination of the key players is subject to their product diversity and core competencies. Some of the major players operating in the global photopheresis market are Terumo Corporation, Malinckrodt Pharmaceuticals, Fresenius Kabi AG, Macopharma, Haemonetics Corporation, and others.
Key Market Movements:
- High prevalence of autoimmune diseases, and growing number of transplants, supported by evolved diagnostics technologies
- Increasing awareness about benefits of apheresis and photopheresis
- Improving reimbursement for autoimmune diseases and organ transplantations
- Evolving medical tourism industry in Asia Pacific and Latin America
Table of Content
1.1 Report Scope and Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Approach Adopted
1.3.4 Top-Down Approach
1.3.5 Bottom-Up Approach
1.3.6 Phase III – Expert Panel Review
1.4 Market Segmentation
2.1 Market Snapshot: Global Photopheresis Products Market
2.1.1 Global Photopheresis Products Market, by Type, 2017 (US$ Mn)
2.1.2 Global Photopheresis Products Market, by Therapeutic Area, 2017 (US$ Mn)
2.1.3 Global Photopheresis Products Market, by Geography, 2017 (US$ Mn)
Photopheresis Products: Market Dynamics and Outlook
3.2 Market Drivers
3.2.1 XXXX XXXX XXXX XXXX XXXX
3.2.1 Driver 2
3.3.1 Challenge 1
3.3.2 Challenge 2
3.4.1 Opportunity 1
3.5 Attractive Investment Proposition, by Geography, 2017
3.6 Competitive Landscape, by Key Players, 2017
Global Photopheresis Products Market, by Type
4.2 Closed System
4.3 Open System
Global Photopheresis Products Market, by Therapeutic Area
5.2 Cutaneous T-cell Lymphoma
5.3 Solid Organ Transplant Rejections
5.4 Autoimmune Diseases
5.5 Graft Versus Host Diseases
Global Photopheresis Products Market, by Geography
You can get the sample copy of this research by Acute Market Reports here: https://www.acutemarketreports.com/request-free-sample/137736
Acute Market Reports is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives.
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
(US/CANADA) Ph.: +1-855-455-8662